-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Workflow
2026-08-14
Build sensitive immunofluorescence, flow cytometry, and western blot workflows around a Cy3 Goat Anti-Mouse IgG (H+L) Antibody. The guide translates HMGB1 biomarker findings from quantitative proteomics into practical orthogonal validation assays while emphasizing controls, storage, and troubleshooting.
-
Fluoxetine HCl and the Biology of Motivation
2026-08-13
Fluoxetine HCl is more than a serotonergic probe: it can help translational researchers separate serotonin transporter effects, developmental programming, reward motivation, and mu opioid receptor biology in depression research.
-
HyperScript™ Reverse Transcriptase for HCC qPCR
2026-08-13
Learn how to use HyperScript™ Reverse Transcriptase for RNA to cDNA conversion when HCC transcripts are scarce, structured, or long. This workflow connects licoricidin pathway research with practical qPCR controls, temperature optimization, and troubleshooting.
-
ZK53 and the Translational Logic of Human ClpP
2026-08-12
ZK53 is a selective human mitochondrial serine protease ClpP activator that converts mitochondrial proteostasis into a tractable cancer research strategy. This thought-leadership analysis connects human ClpP activation with electron transport chain disruption, DNA damage signaling, ferroptosis sensitization, and the broader principle that metabolic state can determine tumor vulnerability.
-
Hesperadin: Aurora B Kinase Workflows
2026-08-12
Build reproducible mitosis assays with Hesperadin, an Aurora B kinase inhibitor suited to phospho-histone H3, microscopy, and DNA-content workflows. The guide connects Aurora B perturbation with checkpoint-complex biology and provides practical setup, optimization, and troubleshooting strategies for cancer research.
-
CA-074 Me: Reliable Cathepsin B Inhibition
2026-08-11
This scenario-based guide explains how CA-074 Me (Cathepsin B inhibitor), SKU A8239, can help researchers distinguish cathepsin B-dependent cell death from solvent, timing, and lysosomal assay artifacts. It covers assay design, formulation, protocol controls, interpretation, and practical vendor-selection criteria.
-
Caspase-3 Colorimetric Assay Kit: Practical Guide
2026-08-10
The Caspase-3 Colorimetric Assay Kit provides a plate-based method for measuring DEVD-dependent caspase-3 activity in biological lysates through release of p-nitroaniline. It is appropriate for relative apoptosis and caspase activity measurement, but it should not be used alone to establish protease identity, pathway causality, or in vivo disease mechanisms.
-
25-Hydroxycholesterol Reprograms Tumor Macrophages
2026-08-09
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that accumulates in lysosomes, activates AMPKα, and reinforces STAT6-dependent ARG1 production in tumor-associated macrophages. The study connects lipid compartmentalization with macrophage-mediated immune suppression and shows that targeting CH25H can improve T cell activity and anti-PD-1 efficacy.
-
Dovitinib: From RTK Inhibition to Cell-State Mapping
2026-08-08
Dovitinib (TKI-258) is a multitargeted RTK inhibitor that can expose how kinase dependence shapes proliferation, ERK/STAT signaling, and apoptosis. This article connects cancer perturbation assays with epithelial organoid research to show how compartment, co-culture, and phospho-state measurements improve mechanistic interpretation.
-
SB743921: From Mitotic Arrest to Assay Insight
2026-08-07
SB743921 is a highly selective kinesin spindle protein inhibitor whose mitotic activity can be interpreted more accurately by separating growth inhibition from cell killing. This article connects its mechanism, potency, model data, and assay design to a more rigorous framework for cancer research.
-
Lipidated Nanophotosensitizers Block Tumor Growth and Metast
2026-08-07
A recent study demonstrates that lipidated nanophotosensitizers can trace and disable tumor extracellular vesicles (TEVs), enabling concurrent inhibition of tumor growth and metastasis through photodynamic therapy. This dual-function strategy addresses longstanding challenges in selectively targeting TEV-mediated communication and offers a novel approach to limiting cancer progression.
-
Calpain Inhibition Restores Offspring Cognition After Matern
2026-08-06
A recent study reveals that excessive calpain activation following maternal non-obstetric surgery during pregnancy disrupts hippocampal BDNF/TrkB signaling and impairs offspring cognition. Pharmacological calpain inhibition with MDL 28170 partially rescues synaptic and cognitive deficits, identifying a mechanistic target for neuroprotection in perinatal models.
-
CB-5083: Optimizing p97 Inhibitor Workflows for Oncology Res
2026-08-06
CB-5083 empowers precise disruption of protein homeostasis, enabling robust cancer cell apoptosis induction and tumor growth inhibition models. This article delivers actionable workflows, troubleshooting insights, and translational best practices for leveraging this advanced p97 inhibitor in cutting-edge oncology and protein quality control research.
-
Solving Lab Challenges with Tofacitinib citrate (CP-690550 c
2026-08-05
This article addresses common laboratory hurdles in immune regulation and inflammatory disorder research, illustrating how Tofacitinib citrate (CP-690550 citrate), SKU A4135, delivers reliable, data-driven solutions for cell viability and cytokine modulation workflows. Integrating scenario-based Q&A and protocol insights, it guides researchers toward reproducible results and robust JAK-STAT pathway interrogation.
-
Uridine, Trisodium Salt: Enhancing RNA Biosynthesis Protocol
2026-08-05
Uridine, Trisodium Salt from APExBIO empowers high-fidelity RNA biosynthesis and vascular response studies, unlocking scalable, RNA-mediated genome engineering workflows. This article provides actionable protocol enhancements and troubleshooting strategies inspired by the latest PRINT technology and comparative data.
451 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page